Baseline aspartate aminotransferase/alanine transaminase ratio is associated with 3-year mortality in peritoneal dialysis patients

作     者：Ruoxi Liao Xueli Zhou Dengyan Ma Jing Tang Hui Zhong Ruoxi Liao;Xueli Zhou;Dengyan Ma;Jing Tang;Hui Zhong

作者机构：Department of NephrologyWest China HospitalSichuan UniversityChengduSichuan 610041China. 

出 版 物：《Chinese Medical Journal》 (中华医学杂志（英文版）)

年 卷 期：2022年第135卷第13期

页      面：1622-1624页

核心收录：

学科分类：1002[医学-临床医学] 100210[医学-外科学(含：普外、骨外、泌尿外、胸心外、神外、整形、烧伤、野战外)] 10[医学] 

基　　金：funded by the National Natural Science Foundation of China(No.82000702) 

主　　题：patients dialysis aspartate 

摘      要：To the Editor:Peritoneal dialysis(PD)is a well-established renal replacement therapyin end-stage renal disease(ESRD)*** significant advances in technologies in recent decades,the mortality of PD patients remains *** prognostic factors for PD patients may help to identify patients at high *** aspartate aminotransferase(AST)/alanine transaminase(ALT)ratio was originally proposed as a marker of hepatic *** recent years,researchers have found this ratio to be related to morbidity and mortality in other populations as well.[1,2]Therefore,we conducted this study to evaluate the prognostic value of the aspartate aminotransferase/alanine transaminase ratio(AST/ALT)ratio in PD patients.